Journal of Hematotherapy · 1995 · 138 citations · 22 references
MedicineHematologyImmunologyCell TherapyStem Cell TransplantationTransplant ImmunologyAllogeneic Stem Cell TransplantationCell-based ImmunotherapyDonor MatchingHistocompatibilityHla MatchingTransplant ImmunotherapyBone Marrow Stem Cell InfusionHla Matching In TransplantationMatched Unrelated Donor TransplantationStem Cell Donor MatchingViral-specific Cytotoxic T Lymphocyte Responses
EBV-induced lymphoproliferative disease (EBV-LPD) is a disorder most commonly associated with the immunocompromise that follows allogeneic organ transplantation. In patients receiving T cell-depleted bone marrow from HLA-mismatched or HLA-matched unrelated donors, the incidence of EBV-LPD is particularly high, ranging from 5 to 30%. Administration of EBV-specific cytotoxic T lymphocytes may be one means of preventing and treating this disease. We now describe a method that allows the routine and timely preparation of large numbers of such cells to allow their safe administration to bone marrow transplant recipients. We also describe how these cells may be genetically marked before infusion, to determine their fate and disposition in vivo.
22
Esperanza B. Papadopoulos, Marc Ladanyi, David Emanuel et al. · New England Journal of Medicine · 1994 · 1.1K citations · Full text
Medicine, Hematology, Immunology +12